73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Activated vitamin D3 treatment may reduce the risk of arsenic-mediated skin cancer

Activated vitamin D3 treatment may reduce the risk of arsenic-mediated skin cancer

by Shibaura Institute of TechnologyThe risk of cancer associated with long-term exposure to arsenic in drinking water can be mitigated through regular treatment with calcitriol, an activated form of v

Activated vitamin D3 treatment may reduce the risk of arsenic-mediated skin cancer

by Shibaura Institute of TechnologyThe risk of cancer associated with long-term exposure to arsenic in drinking water can be mitigated through regular treatment with calcitriol, an activated form of v
Two genes slow down the development of intestinal tumors

Two genes slow down the development of intestinal tumors

byThe Francis Crick InstituteImage of two intestinaltumours, one a control (top) and one with the genes NEDD4 and NEDD4L deleted (bottom). Credit: The Francis Crick InstituteBenign i

Two genes slow down the development of intestinal tumors

byThe Francis Crick InstituteImage of two intestinaltumours, one a control (top) and one with the genes NEDD4 and NEDD4L deleted (bottom). Credit: The Francis Crick InstituteBenign i
A quicker answer on cancer, with waits cut from 84 days to 6

A quicker answer on cancer, with waits cut from 84 days to 6

bySwansea UniversityCredit: CC0 Public DomainA rapid diagnosis centre has cut waiting times for patients with non-specific symptoms who may have cancer from 84 days to 6, and costs less than cur

A quicker answer on cancer, with waits cut from 84 days to 6

bySwansea UniversityCredit: CC0 Public DomainA rapid diagnosis centre has cut waiting times for patients with non-specific symptoms who may have cancer from 84 days to 6, and costs less than cur
Finding familiar pathways in kidney cancer

Finding familiar pathways in kidney cancer

byThomas Jefferson UniversityCredit: CC0 Public Domainp53 is the most famous cancer gene, not least because it's involved in causing over 50% of all cancers. When a cell loses its p53 gene—w

Finding familiar pathways in kidney cancer

byThomas Jefferson UniversityCredit: CC0 Public Domainp53 is the most famous cancer gene, not least because it's involved in causing over 50% of all cancers. When a cell loses its p53 gene—w
New therapeutic vaccine gives hope against an aggressive breast cancer

New therapeutic vaccine gives hope against an aggressive breast cancer

by Dennis ThompsonAn experimental vaccine could offer fresh hope to women diagnosed with an aggressive and hard-to-treat form of breast cancer, new research suggests.The vaccine appears to be safe and

New therapeutic vaccine gives hope against an aggressive breast cancer

by Dennis ThompsonAn experimental vaccine could offer fresh hope to women diagnosed with an aggressive and hard-to-treat form of breast cancer, new research suggests.The vaccine appears to be safe and
Scientists create an scRNA-seq atlas of the multiple myeloma immune microenvironment across disease stages

Scientists create an scRNA-seq atlas of the multiple myeloma immune microenvironment across disease stages

byVIB (the Flanders Institute for Biotechnology)The MM microenvironment is characterized by the presence of T cells with an exhausted phenotype. Credit:Journal of Hematology & Oncology

Scientists create an scRNA-seq atlas of the multiple myeloma immune microenvironment across disease stages

byVIB (the Flanders Institute for Biotechnology)The MM microenvironment is characterized by the presence of T cells with an exhausted phenotype. Credit:Journal of Hematology & Oncology
Scientists uncover novel DNA repair mechanism for key cancer target

Scientists uncover novel DNA repair mechanism for key cancer target

byThe Francis Crick InstituteGraphical Abstract. Credit:Molecular Cell(2022). DOI: 10.1016/j.molcel.2022.11.008Scientists at the Francis Crick Institute, in collaboration with Artios

Scientists uncover novel DNA repair mechanism for key cancer target

byThe Francis Crick InstituteGraphical Abstract. Credit:Molecular Cell(2022). DOI: 10.1016/j.molcel.2022.11.008Scientists at the Francis Crick Institute, in collaboration with Artios
New method for early detection of relapse in the blood cancer disease myelodysplastic syndrome

New method for early detection of relapse in the blood cancer disease myelodysplastic syndrome

by Karolinska InstitutetCredit: CC0 Public DomainResearchers at the Department of Medicine, Huddinge (MedH), Magnus Tobiasson and Eva Hellström-Lindberg have, together with the Nordic MDS group,

New method for early detection of relapse in the blood cancer disease myelodysplastic syndrome

by Karolinska InstitutetCredit: CC0 Public DomainResearchers at the Department of Medicine, Huddinge (MedH), Magnus Tobiasson and Eva Hellström-Lindberg have, together with the Nordic MDS group,
Key discovery advances fight to reduce breast cancer recurrence

Key discovery advances fight to reduce breast cancer recurrence

byDuke-NUS Medical SchoolLoss of Gα13 in ER+ breast cancer cells leads to increased cell growth and tumour development, suggesting that Gα13 may suppress tumours in this subtype of cancer. Credi

Key discovery advances fight to reduce breast cancer recurrence

byDuke-NUS Medical SchoolLoss of Gα13 in ER+ breast cancer cells leads to increased cell growth and tumour development, suggesting that Gα13 may suppress tumours in this subtype of cancer. Credi
Small device for earlier ovarian cancer detection

Small device for earlier ovarian cancer detection

by Emily Dieckman,University of ArizonaJennifer Barton, director of the University of Arizona BIO5 Institute and Thomas R. Brown Distinguished Chair in Biomedical Engineering, has spent years de

Small device for earlier ovarian cancer detection

by Emily Dieckman,University of ArizonaJennifer Barton, director of the University of Arizona BIO5 Institute and Thomas R. Brown Distinguished Chair in Biomedical Engineering, has spent years de
Neoantigen DNA vaccine shows promise against aggressive breast cancer in clinical trial

Neoantigen DNA vaccine shows promise against aggressive breast cancer in clinical trial

by Julia Evangelou Strait,Washington University School of MedicineA small clinical trial conducted at WashU Medicine shows promising results for patients with triple-negative breast cancer who r

Neoantigen DNA vaccine shows promise against aggressive breast cancer in clinical trial

by Julia Evangelou Strait,Washington University School of MedicineA small clinical trial conducted at WashU Medicine shows promising results for patients with triple-negative breast cancer who r
Patient-reported outcomes predict aromatase inhibitor adherence

Patient-reported outcomes predict aromatase inhibitor adherence

by SWOGCredit: CC0 Public DomainIf you want to predict which breast cancer patients will most likely stop taking aromatase inhibitors, check out their own responses to the health questions patients co

Patient-reported outcomes predict aromatase inhibitor adherence

by SWOGCredit: CC0 Public DomainIf you want to predict which breast cancer patients will most likely stop taking aromatase inhibitors, check out their own responses to the health questions patients co